Jeffrey S. Miller
About
Jeffrey S. Miller is a scholar working on Immunology, Hematology and Oncology.
According to data from OpenAlex, Jeffrey S. Miller has authored 607 papers receiving a total of 32.9k indexed citations (citations by other indexed papers that have themselves been cited), including 383 papers in Immunology, 217 papers in Hematology and 200 papers in Oncology. Recurrent topics in Jeffrey S. Miller's work include Immune Cell Function and Interaction (348 papers), Hematopoietic Stem Cell Transplantation (176 papers) and T-cell and B-cell Immunology (159 papers). Jeffrey S. Miller is often cited by papers focused on Immune Cell Function and Interaction (348 papers), Hematopoietic Stem Cell Transplantation (176 papers) and T-cell and B-cell Immunology (159 papers). Jeffrey S. Miller collaborates with scholars based in United States, United Kingdom and Sweden. Jeffrey S. Miller's co-authors include Daniel J. Weisdorf, Bruce R. Blazar, Sarah Cooley, Michael R. Verneris, Todd E. DeFor, John E. Wagner, Philip B. McGlave, Valarie McCullar, Martin Felices and Catherine M. Verfaillie and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
In The Last Decade
Jeffrey S. Miller
595 papers receiving 32.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey S. Miller United States | 96 | 21.4k | 11.8k | 9.4k | 4.0k | 2.1k | 607 | 32.9k | ||
| H. Robson MacDonald Switzerland | 98 | 21.3k 1.0× | 5.6k 0.5× | 3.0k 0.3× | 10.2k 2.6× | 2.2k 1.0× | 479 | 34.4k | ||
| Timothy J. Ley United States | 70 | 6.6k 0.3× | 4.3k 0.4× | 4.7k 0.5× | 10.9k 2.7× | 1.4k 0.6× | 227 | 22.6k | ||
| Neal S. Young United States | 99 | 10.1k 0.5× | 3.7k 0.3× | 16.1k 1.7× | 6.0k 1.5× | 3.0k 1.4× | 598 | 35.0k | ||
| Elı́as Campo Spain | 98 | 6.4k 0.3× | 15.0k 1.3× | 2.7k 0.3× | 9.0k 2.3× | 1.9k 0.9× | 656 | 38.7k | ||
| Axel Benner Germany | 79 | 4.2k 0.2× | 6.4k 0.5× | 6.1k 0.6× | 9.7k 2.4× | 1.5k 0.7× | 398 | 24.1k | ||
| Lee M. Nadler United States | 79 | 14.5k 0.7× | 6.5k 0.5× | 3.6k 0.4× | 5.1k 1.3× | 1.4k 0.6× | 268 | 24.6k | ||
| Donna Neuberg United States | 113 | 9.5k 0.4× | 14.0k 1.2× | 12.4k 1.3× | 14.4k 3.6× | 2.0k 0.9× | 719 | 46.3k | ||
| Gareth J. Morgan United Kingdom | 87 | 4.6k 0.2× | 10.1k 0.9× | 17.2k 1.8× | 15.0k 3.7× | 1.7k 0.8× | 852 | 30.5k | ||
| Peter Johnson United Kingdom | 78 | 7.0k 0.3× | 7.5k 0.6× | 1.7k 0.2× | 5.5k 1.4× | 1.3k 0.6× | 612 | 23.8k | ||
| John A. Hansen United States | 80 | 13.2k 0.6× | 3.7k 0.3× | 11.8k 1.3× | 2.3k 0.6× | 2.3k 1.1× | 386 | 24.6k |
Countries citing papers authored by Jeffrey S. Miller
Since
Specialization
Citations
This map shows the geographic impact of Jeffrey S. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Miller more than expected).
Fields of papers citing papers by Jeffrey S. Miller
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jeffrey S. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Miller. The network helps show where Jeffrey S. Miller may publish in the future.
Co-authorship network of co-authors of Jeffrey S. Miller
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Miller. A scholar is included among the top collaborators of Jeffrey S. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Miller. Jeffrey S. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lozada, John R., Andrew Elliott, Mark G. Evans, et al.. (2025). Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting. Cancer Research Communications. 5(2). 318–326.
2.
Wang, Sam C., et al.. (2024). Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. Journal for ImmunoTherapy of Cancer. 12(7). e008959–e008959.
3.
Baik, June, Martin Felices, Ashley Yingst, et al.. (2020). Therapeutic effect of TRC105 and decitabine combination in AML xenografts. Heliyon. 6(10). e05242–e05242.
4.
Bachanová, Veronika, Daniel J. Weisdorf, Tao Wang, et al.. (2018). Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis. Biology of Blood and Marrow Transplantation. 25(5). 949–954.
5.
Cooley, Sarah, Peter Parham, & Jeffrey S. Miller. (2018). Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation. Blood. 131(10). 1053–1062.
6.
Björklund, Andreas T., Mattias Carlsten, Ebba Sohlberg, et al.. (2018). Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML. Clinical Cancer Research. 24(8). 1834–1844.
7.
Margolin, Kim, Chihiro Morishima, Vamsidhar Velcheti, et al.. (2018). Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 24(22). 5552–5561.
8.
Sarhan, Dhifaf, Keli L. Hippen, Xianghua Luo, et al.. (2018). Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37. Cancer Immunology Research. 6(7). 766–775.
9.
Sarhan, Dhifaf, Frank Cichocki, Bin Zhang, et al.. (2016). Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells. Cancer Research. 76(19). 5696–5706.
10.
Vallera, Daniel A., Martin Felices, Ron McElmurry, et al.. (2016). IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clinical Cancer Research. 22(14). 3440–3450.
11.
Brunstein, Claudio G., Jeffrey S. Miller, David H. McKenna, et al.. (2015). Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. Blood. 127(8). 1044–1051.
12.
Jha, Gautam, et al.. (2012). Randomized Phase II Study of IL-2 With or Without an Allogeneic Large Multivalent Immunogen Vaccine for the Treatment of Stage IV Melanoma. American Journal of Clinical Oncology. 37(3). 261–265.
13.
Foley, Bree, Sarah Cooley, Michael R. Verneris, et al.. (2011). Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood. 119(11). 2665–2674.
14.
Ahn, Yong‐Oon, Jan Spanholtz, Hongbo Wang, et al.. (2011). Natural Killer Cell Differentiation from Hematopoietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell–Supported Methods. Biology of Blood and Marrow Transplantation. 18(4). 536–545.
15.
Bishop, Michael, Edwin P. Alyea, Mitchell S. Cairo, et al.. (2011). National Cancer Institute’s First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee. Biology of Blood and Marrow Transplantation. 17(4). 443–454.
16.
Brunstein, Claudio G., Jeffrey S. Miller, Qing Cao, et al.. (2010). Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 117(3). 1061–1070.
17.
Brunstein, Claudio G., Juliet N. Barker, Daniel J. Weisdorf, et al.. (2007). Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 110(8). 3064–3070.
18.
Lickliter, Jason D., Robert A. Kratzke, Phuong Nguyen, Gloria A. Niehans, & Jeffrey S. Miller. (1999). Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis. Experimental Hematology. 27(10). 1519–1527.
19.
Buchman, E, et al.. (1991). Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis.. PubMed. 66(3). 257–62.
20.
Simpson, Nancy E., Louis Dallaire, James R. Miller, et al.. (1979). Antenatal diagnosis of neural tube defects in Canada: extension of a collaborative study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 120(6). 653–7.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by H. Robson MacDonald Breakdown of academic impact, for papers by Timothy J. Ley Breakdown of academic impact, for papers by Neal S. Young Breakdown of academic impact, for papers by Elı́as Campo Breakdown of academic impact, for papers by Axel Benner Breakdown of academic impact, for papers by Lee M. Nadler Breakdown of academic impact, for papers by Donna Neuberg Breakdown of academic impact, for papers by Gareth J. Morgan Breakdown of academic impact, for papers by Peter Johnson Breakdown of academic impact, for papers by John A. Hansen